Pacira | PCRX - 资产

金融业

USD

USD 1.21B

现金及等价物

USD 144.31M

USD 50.74M

USD 514.96M

USD 108.79M

USD 367.66M

USD 4.63M

USD 40.24M

790

EPS每股收益

USD 0.6

股本和储备

USD 653.89M

USD 126.64M

债务利息支出

USD 3.7M

USD 2.3M

USD 367.66M

USD 1.09B

USD 2.92M

USD 172.75M

USD 4.63M

普通股股本

USD 39.31M

38.58

USD 571K

USD 177M

销售和管理费用

USD 83.88M

USD 150.37M

贸易债权人

USD 14.01M

应收帐款人

USD 125.64M

	资产	更改		日
Assertio Holdings	USD 319.77M		46M	2025-09
Astellas Pharma	JPY 3.57T		36.87B	2026-03
Bristol-Myers Squibb	USD 86.48B		3.56B	2026-03
Cara Therapeutics	USD 32.07M		6.95M	2025-12
Coherus Biosciences	USD 258.34M		258.18M	2025-12
Heron Therapeutics	USD 246.22M		9.66M	2026-03
Ironwood Pharmaceuticals	USD 434.57M		37.66M	2026-03
J&J	USD 200.89B		1.68B	2026-03
Ligand Pharmaceuticals	USD 1.53B		28.53M	2026-03
Nektar Therapeutics	USD 280.41M		20.94M	2025-12
Novo Nordisk	DKK 559.22B		16.32B	2026-03
Omeros	USD 200.57M		34.59M	2025-06
Pacira	USD 1.21B		56.38M	2026-03
Perrigo	USD 7.98B		551.9M	2026-03
Pfizer	USD 207.62B		542M	2026-03
Supernus Pharmaceuticals	USD 1.5B		48.08M	2026-03
Teva Pharmaceutical Industries	USD 40.04B		708M	2026-03
Xeris Pharmaceuticals	USD 392.01M		8.49M	2026-03
Xoma	USD 263.15M		39.7M	2025-09
Zoetis	USD 15.15B		313M	2026-03